Another major player has joined the growing list of companies embracing Bitcoin as a key financial asset.
The increasing adoption of the flagship cryptocurrency by institutions signals a shift in how businesses approach treasury management and long-term value preservation.
Biopharmaceutical firm Hoth Therapeutics has revealed plans to acquire $1 million worth of Bitcoin to strengthen its treasury reserves. The decision, approved by the company’s Board of Directors, underscores the rising confidence in Bitcoin as a reliable store of value. CEO Robb Kine highlighted Bitcoin’s inflation-resistant characteristics and its growing acceptance as a primary asset class, driven by institutional interest and the approval of Bitcoin ETFs.
This announcement comes during a wave of enthusiasm in the cryptocurrency market. Bitcoin recently hit a new all-time high of $97,400, fueled by robust inflows into ETFs and positive market sentiment following Donald Trump’s reelection. Speculation about a strategic U.S. Bitcoin reserve has further bolstered optimism. The launch of Bitcoin ETF options today has added to the excitement, with analysts anticipating strengthened market momentum.
Hoth Therapeutics’ move reflects the broader trend of corporations turning to Bitcoin to diversify their financial strategies, reinforcing its status as a cornerstone asset in the evolving financial landscape.
Bitcoin may be gearing up for another rally, and one key macro trend could be the driving force: a surge in global liquidity.
Bitcoin briefly surged past $86,000 on Tuesday, reaching levels not seen since early April, before slipping back slightly.
The Trump administration is exploring the idea of leveraging tariff revenues to build a national Bitcoin reserve, signaling a broader shift in how digital assets could be integrated into U.S. economic policy.
Public companies ramped up their Bitcoin holdings in early 2025, with total corporate reserves growing by more than 95,000 BTC in the first quarter alone, according to data shared by Bitwise.